What is Relay Therapeutics, Inc.'s net investment in lease?

Relay Therapeutics, Inc. (RLAY) reported net investment in lease of $38.59M in Q1 2026.

How has Relay Therapeutics, Inc.'s net investment in lease changed year-over-year?

Relay Therapeutics, Inc.'s net investment in lease decreased by 23.0% year-over-year, from $50.14M to $38.59M.

What is the long-term trend for Relay Therapeutics, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s net investment in lease has grown at a 12.1% compound annual growth rate (CAGR), from $22.58M to $39.99M.

Relay Therapeutics, Inc. RLAY Net Investment in Lease

Net Investment in Lease at other companies

CelcuityCELC

——

Revolution Medicines, Inc.RVMD

——

Ligand PharmaceuticalsLGND

——

IDEAYA Biosciences, Inc.IDYA

——

Cogent Biosciences, Inc.COGT

——

Tango TherapeuticsTNGX

——

Other financials

Income statement

See full

Revenue$3.0M-60.9%

Operating income-$78.6M+7.4%

Net income-$73.3M+4.9%

EPS (diluted)-$0.41+10.9%

Balance sheet

See full

Cash & equivalents$204.6M+119%

Total debt$31.6M-33.1%

Total equity$642.2M-10.9%

Total assets$699.6M-12.5%

Cash flow

See full

Operating cash flow-$51.1M+30.2%

CapEx$1.0K—

Free cash flow-$44.9M+22.5%

Valuation

See full

Market cap$3.8B+300%

Profitability

See full

Operating margin-2,776.6%-820pp

Net margin-2,554.1%-745pp

FCF margin-1,536%-429pp

Returns & leverage

See full

Return on equity-40%-4.3pp

Debt / equity0×0.0×

Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s net investment in lease?: Relay Therapeutics, Inc. (RLAY) reported net investment in lease of $38.59M in Q1 2026.
How has Relay Therapeutics, Inc.'s net investment in lease changed year-over-year?: Relay Therapeutics, Inc.'s net investment in lease decreased by 23.0% year-over-year, from $50.14M to $38.59M.
What is the long-term trend for Relay Therapeutics, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s net investment in lease has grown at a 12.1% compound annual growth rate (CAGR), from $22.58M to $39.99M.